Key Points
- Doximity CAO Siddharth Sitaram sold 2,523 shares for $84,041 at an average price of $33.31, under a pre-arranged Rule 10b5-1 plan to cover tax withholding on vested equity awards.
- After the sale, Sitaram retained 104,085 shares, valued at about $3.47 million—a 2.37% reduction in his holdings.
- Doximity beat quarterly earnings estimates, reporting $0.36 per share versus analysts’ $0.19 consensus; analysts’ overall rating was “Hold,” with an average price target of $30.59.
Doximity, Inc. (NYSE:DOCS - Get Free Report) CAO Siddharth Sitaram sold 2,523 shares of Doximity stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $33.31, for a total transaction of $84,041.13. Following the completion of the sale, the chief accounting officer owned 104,085 shares of the company's stock, valued at $3,467,071.35. This represents a 2.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Siddharth Sitaram also recently made the following trade(s):
- On Wednesday, October 14th, Siddharth Sitaram sold 2,613 shares of Doximity stock. The shares were sold at an average price of $30.68, for a total transaction of $80,166.84.
- On Tuesday, September 15th, Siddharth Sitaram sold 2,077 shares of Doximity stock. The shares were sold at an average price of $26.02, for a total transaction of $54,043.54.
Doximity Trading Down 5.0%
Shares of DOCS stock opened at $31.14 on Wednesday. Doximity, Inc. has a 12-month low of $17.15 and a 12-month high of $51.85. The firm's 50 day moving average is $30.00 and its 200 day moving average is $25.27. The stock has a market capitalization of $5.56 billion, a P/E ratio of 43.25, a P/E/G ratio of 35.09 and a beta of 1.29.
Doximity (NYSE:DOCS - Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.17. The business had revenue of $174.54 million during the quarter. Doximity had a net margin of 21.12% and a return on equity of 15.80%. The company's revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $0.45 EPS. As a group, equities analysts predict that Doximity, Inc. will post 0.72 earnings per share for the current year.
Wall Street Analyst Weigh In
DOCS has been the topic of a number of research reports. Wolfe Research upgraded Doximity to an "outperform" rating in a research note on Thursday, August 13th. Barclays upped their price objective on Doximity from $27.00 to $30.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 11th. Royal Bank Of Canada increased their target price on Doximity from $28.00 to $34.00 and gave the company an "outperform" rating in a report on Friday, November 6th. Evercore set a $35.00 target price on Doximity in a research report on Tuesday, September 29th. Finally, Freedom Capital downgraded Doximity from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, September 8th. Eight investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $30.59.
View Our Latest Research Report on DOCS
Hedge Funds Weigh In On Doximity
A number of institutional investors have recently bought and sold shares of DOCS. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Doximity in the third quarter worth $45,000. Versant Capital Management Inc lifted its stake in shares of Doximity by 1,176.9% during the 3rd quarter. Versant Capital Management Inc now owns 1,826 shares of the company's stock valued at $52,000 after buying an additional 1,683 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of Doximity by 59.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,855 shares of the company's stock valued at $53,000 after buying an additional 695 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Doximity by 79.8% in the 3rd quarter. Bessemer Group Inc. now owns 1,910 shares of the company's stock worth $54,000 after buying an additional 848 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in Doximity by 111.0% in the 1st quarter. Parallel Advisors LLC now owns 2,560 shares of the company's stock worth $60,000 after buying an additional 1,347 shares during the period. 87.19% of the stock is owned by institutional investors.
About Doximity
(
Get Free Report)
Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals. The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].